Thomas Hammerstrom
- Hepatology top 5%
- Hepatitis C virus research 2
- Virology top 10%
- HIV Research and Treatment 2
- Pharmaceutical Science top 5%
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment 3
- HIV/AIDS Research and Interventions 2
-
- Optimal Experimental Design Methods 4
-
- Air Quality and Health Impacts 2
-
- Crystallization and Solubility Studies 2
-
- Hepatitis B Virus Studies 2
- Co-authors
- Yi TsongStacey C. FitzSimmonsPeter R. DurieGreg A. BurkhartDrucy BorowitzRichard J. GrandAlbert B. LowenfelsJohn D. Lloyd‐Still
- Journals
- Journal of Biopharmaceutical Statistics (2 papers)Pharmacoepidemiology and Drug Safety (2 papers)Drug Information Journal (2 papers)
- Partner nations
- United StatesNetherlandsItaly
In The Last Decade
Thomas Hammerstrom
15 papers receiving 621 citations
Peers
Comparison fields: 5 of 94
- Hepatology 131
- Virology 63
- Pharmaceutical Science 66
- Infectious Diseases 134
- Psychiatry and Mental health 77
Countries citing papers authored by Thomas Hammerstrom
This map shows the geographic impact of Thomas Hammerstrom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Hammerstrom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Hammerstrom more than expected).
Fields of papers citing papers by Thomas Hammerstrom
This network shows the impact of papers produced by Thomas Hammerstrom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Hammerstrom. The network helps show where Thomas Hammerstrom may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Hammerstrom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 130 | |
| 2 | 2012 | 56 | |
| 3 | 2012 | 9 | |
| 4 | 2011 | 1 | |
| 5 | 2011 | 46 | |
| 6 | 2008 | 3 | |
| 7 | 1997 | 184 | |
| 8 | 1997 | 35 | |
| 9 | 1996 | 24 | |
| 10 | 1996 | 34 | |
| 11 | 1996 | 68 | |
| 12 | 1995 | 10 | |
| 13 | 1994 | 0 | |
| 14 | 1992 | 41 | |
| 15 | 1989 | 5 | |
| 16 | 1981 | 6 |
About Thomas Hammerstrom
Thomas Hammerstrom is a scholar working on Virology, Statistics and Probability, Management Science and Operations Research, Toxicology and Statistics, Probability and Uncertainty, having authored 16 papers that have together received 652 indexed citations. Recurring topics across this work include Optimal Experimental Design Methods (4 papers), HIV/AIDS drug development and treatment (3 papers), Air Quality and Health Impacts (2 papers), HIV Research and Treatment (2 papers), Crystallization and Solubility Studies (2 papers), HIV/AIDS Research and Interventions (2 papers), Hepatitis B Virus Studies (2 papers) and Hepatitis C virus research (2 papers). The work is most often cited by research in Hepatology (131 citations), Virology (63 citations), Pharmaceutical Science (66 citations), Infectious Diseases (134 citations) and Psychiatry and Mental health (77 citations). Thomas Hammerstrom has collaborated with scholars based in United States, Netherlands and Italy. Frequent co-authors include Yi Tsong, Stacey C. FitzSimmons, Peter R. Durie, Greg A. Burkhart, Drucy Borowitz, Richard J. Grand, Albert B. Lowenfels, John D. Lloyd‐Still, Debra Birnkrant and Frederick W. Lipfert. Their work appears in journals such as Journal of Biopharmaceutical Statistics, Pharmacoepidemiology and Drug Safety, Drug Information Journal, BMJ Open and AIDS Patient Care and STDs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.